F J Lopez-Longo
Overview
Explore the profile of F J Lopez-Longo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kuster S, Jordan S, Elhai M, Held U, Steigmiller K, Bruni C, et al.
RMD Open
. 2022 Nov;
8(2).
PMID: 36328401
Objectives: Tocilizumab showed trends for improving skin fibrosis and prevented progression of lung fibrosis in systemic sclerosis (SSc) in randomised controlled clinical trials. We aimed to assess safety and effectiveness...
2.
Hernandez Cruz B, Alonso F, Calvo Alen J, Pego-Reigosa J, Lopez-Longo F, Galindo-Izquierdo M, et al.
Lupus
. 2019 Dec;
29(1):27-36.
PMID: 31801040
Background: Systemic lupus erythematosus (SLE) is regarded as a prototype autoimmune disease because it can serve as a means for studying differences between ethnic minorities and sex. Traditionally, all Hispanics...
3.
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho J, et al.
Ann Rheum Dis
. 2019 Apr;
78(7):979-987.
PMID: 30967395
Objective: To assess the safety and efficacy of rituximab in systemic sclerosis (SSc) in clinical practice. Methods: We performed a prospective study including patients with SSc from the European Scleroderma...
4.
Torrente-Segarra V, Salman Monte T, Rua-Figueroa I, de Una-Alvarez J, Balboa-Barreiro V, Lopez-Longo F, et al.
Semin Arthritis Rheum
. 2018 Oct;
48(6):1025-1029.
PMID: 30344081
Objectives: To identify patterns (clusters) of damage manifestation within a large cohort of juvenile SLE (jSLE) patients and evaluate their possible association with mortality. Methods: This is a multicentre, descriptive,...
5.
Rodriguez-Jimenez P, Mir-Viladrich I, Chicharro P, Solano-Lopez G, Lopez-Longo F, Taxonera C, et al.
Actas Dermosifiliogr (Engl Ed)
. 2018 Jun;
109(7):584-601.
PMID: 29871738
Patients with chronic inflammatory diseases being treated with immunosuppressive drugs, and with tumor necrosis factor inhibitors in particular, have an increased risk of infection by Mycobacterium tuberculosis. Screening for latent...
6.
Garcia-Montoya L, Saenz-Tenorio C, Janta I, Menarguez J, Lopez-Longo F, Monteagudo I, et al.
Rheumatol Int
. 2016 Nov;
37(4):663-669.
PMID: 27853859
Hemophagocytic lymphohistiocytosis (HLH) is a very rare syndrome with a mortality up to 95% of cases if not treated. It is characterised by an excessive activation of the immune system...
7.
Riveros Frutos A, Casas I, Rua-Figueroa I, Lopez-Longo F, Calvo-Alen J, Galindo M, et al.
Lupus
. 2016 Nov;
26(7):698-706.
PMID: 27799439
Objective The objective of this study was to describe the demographic, clinical, and immunological manifestations of systemic lupus erythematosus (SLE) in male patients. Methods A cross-sectional, multicenter study was carried...
8.
Martinez-Barrio J, Ovalles-Bonilla J, Lopez-Longo F, Gonzalez C, Montoro M, Valor L, et al.
Clin Exp Rheumatol
. 2015 Nov;
33(6):788-94.
PMID: 26575830
Objectives: This paper aims to identify clinical and serological differences, damage accrual and mortality, in juvenile, adult and late-onset SLE. Methods: We conducted our study with patients fulfilling SLE classification...
9.
Valor L, Hernandez-Florez D, De La Torre I, Del Rio T, Nieto J, Gonzalez C, et al.
Clin Exp Rheumatol
. 2015 Aug;
33(6):805-11.
PMID: 26314759
Objectives: The aim of this study was to examine the extent to which infliximab (IFX) serum levels impact disease activity in rheumatoid arthritis (RA) patients. Methods: In this cross sectional...
10.
Pego-Reigosa J, Rua-Figueroa I, Lopez-Longo F, Galindo-Izquierdo M, Calvo-Alen J, Olive-Marques A, et al.
Lupus
. 2014 Dec;
24(7):720-9.
PMID: 25516473
Objectives: The objectives of this paper are to study the impact of disease activity in a large cohort of patients with systemic lupus erythematosus (SLE) and estimate the rate of...